Interferon-, a Th 1 Cytokine , Regulates Fat Inflammation
暂无分享,去创建一个
P. Libby | G. Sukhova | K. Shimizu | I. Gotsman | V. Z. Rocha | E. Folco | A. Vernon
[1] P. Libby,et al. The multiple facets of the fat tissue. , 2008, Thyroid : official journal of the American Thyroid Association.
[2] G. Hansson,et al. Innate immunity, macrophage activation, and atherosclerosis , 2007, Immunological reviews.
[3] J J Chen,et al. Selection of differentially expressed genes in microarray data analysis , 2007, The Pharmacogenomics Journal.
[4] K. Flegal,et al. Epidemiology of Obesity , 2014 .
[5] Leif E. Peterson,et al. T-Cell Accumulation and Regulated on Activation, Normal T Cell Expressed and Secreted Upregulation in Adipose Tissue in Obesity , 2007, Circulation.
[6] A. Saltiel,et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.
[7] Christian Weber,et al. Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[8] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[9] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[10] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[11] R. Kitazawa,et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.
[12] K. Flegal,et al. Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.
[13] G. Hansson,et al. Inflammation and atherosclerosis. , 2006, Annual review of pathology.
[14] Ian Janssen,et al. Vascular Risks and Management of Obesity in Children and Adolescents , 2006, Vascular health and risk management.
[15] Ildikó Kriszbacher,et al. Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.
[16] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[17] K. Flegal,et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.
[18] F. Mach,et al. Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice , 2004, Circulation research.
[19] K. Wellen,et al. Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.
[20] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[21] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[22] J. Pober,et al. Interferon-γ elicits arteriosclerosis in the absence of leukocytes , 2000, Nature.
[23] J. Pober,et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. , 2000, Nature.
[24] P. Libby,et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. , 1999, The Journal of clinical investigation.
[25] A. Tall,et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.
[26] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.
[27] R. Schreiber,et al. Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.
[28] D. Easty,et al. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[29] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.
[30] K. Feingold,et al. In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. , 1992, Endocrinology.
[31] G. Hansson,et al. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.
[32] W. Fiers,et al. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. , 1992, Endocrinology.
[33] A. Clowes,et al. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. , 1988, Circulation research.
[34] R. Krishnan,et al. Effects of γ-Interferon on the Endocrine System: Results from a Phase I Study , 1987 .
[35] R. Krishnan,et al. Effects of gamma-interferon on the endocrine system: results from a phase I study. , 1987, Cancer research.
[36] B. Aggarwal,et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.